INT141565

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.19
First Reported 2007
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 7
Total Number 7
Disease Relevance 2.61
Pain Relevance 0.39

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

nucleus (Cdt1) cell cycle (Cdt1) DNA binding (Cdt1)
Cdt1 (Mus musculus)
Pain Link Frequency Relevance Heat
Antinociceptive 1 93.20 High High
Inflammation 49 92.40 High High
cytokine 53 89.20 High High
Hyperalgesia 1 83.88 Quite High
fifth nerve 3 50.00 Quite Low
Quantitative sensory testing 32 38.04 Quite Low
cOX1 1 25.00 Low Low
COX2 1 25.00 Low Low
Pain 16 21.36 Low Low
rheumatoid arthritis 88 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Cancer 5 99.68 Very High Very High Very High
Necrosis 5 99.44 Very High Very High Very High
Repression 268 98.88 Very High Very High Very High
Skin Diseases 2 93.56 High High
INFLAMMATION 50 92.40 High High
Hyperalgesia 1 83.88 Quite High
Systemic Sclerosis 34 77.52 Quite High
Limited Scleroderma 1 74.60 Quite High
Diffuse Scleroderma 1 72.48 Quite High
Zygomatic Fractures 2 71.36 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
These highly expressed genes included cell cycle genes CENPE, CDC7 and CDT1, FGF5, tumor necrosis factor receptor superfamily member 12A (TNFRSF12A) and TRAF interacting protein (TRIP).
Gene_expression (expressed) of CDT1 associated with necrosis and cancer
1) Confidence 0.19 Published 2009 Journal Mediators of Inflammation Section Body Doc Link PMC2768824 Disease Relevance 1.01 Pain Relevance 0.10
When two CaRRE 1 motifs were introduced in the Dup175 exon (Dup175CA10+13), splicing was completely repressed even in the absence of CaMK IV activity (Figure 4A, lanes 11 and 12).
Gene_expression (introduced) of Dup175
2) Confidence 0.16 Published 2007 Journal PLoS Biology Section Body Doc Link PMC1790950 Disease Relevance 0.19 Pain Relevance 0
CaRRE 2 was inserted at the +3 position of the Dup175 exon, the same position relative to the 3?
Gene_expression (exon) of Dup175
3) Confidence 0.16 Published 2007 Journal PLoS Biology Section Body Doc Link PMC1790950 Disease Relevance 0.20 Pain Relevance 0
This effect was due to the introduced CaRRE 1, because a small point mutation in the element reduced its effect, and replacement with a neutral IgM sequence at the same position in Dup175 exon was not able to confer the repression (Figure 4A, lanes 5–8).
Gene_expression (exon) of Dup175 associated with repression
4) Confidence 0.16 Published 2007 Journal PLoS Biology Section Body Doc Link PMC1790950 Disease Relevance 0.36 Pain Relevance 0
In contrast, the E21 exon alone, when fused to the Dup175 exon 3?
Gene_expression (exon) of Dup175
5) Confidence 0.16 Published 2007 Journal PLoS Biology Section Body Doc Link PMC1790950 Disease Relevance 0.43 Pain Relevance 0
Significant differences (p < 0.05) between control group and test side 1 week after surgery were shown for CDT (?
Gene_expression (shown) of CDT
6) Confidence 0.03 Published 2010 Journal Head Face Med Section Body Doc Link PMC2984556 Disease Relevance 0.07 Pain Relevance 0
Intraperitoneal injection of BjV but not of CdtV induced the release and PGD(2) at 30 min and of PGE(2) from 3 up to 12 h after injection.
Gene_expression (injection) of CdtV
7) Confidence 0.01 Published 2007 Journal Toxicon Section Abstract Doc Link 17241651 Disease Relevance 0.35 Pain Relevance 0.29

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox